BACK
Pre-Clinical Vaccine Targets Nerve Cell Plaques, Slows Down Alzheimer's
interestingengineering.com

Pre-Clinical Vaccine Targets Nerve Cell Plaques, Slows Down Alzheimer's

Researchers developed a new vaccine targeting plaque in nerve cells to slow down the progressing of Alzheimer's disease. Read more to find out.

Health

One of the most tragic diseases a human can ever experience is for sure losing all or at least a big part of the memories you've collected throughout your life. As the condition gets worse over the years, it is even harder to hinder.

However, a new vaccine developed by the researchers from the University of South Florida Health (USF Health), has shown that immunotherapy targeting the neurotoxic forms of peptide amyloid-beta which cause forming plaques between nerve cells, might prevent Alzheimer's disease's from progressing further.

The research on vaccine trials has been published in the Journal of Alzheimer’s Disease.

Click to continue reading

What appears crucial about the new vaccine is that it has the potential of working without inflammatory side effects. As inflammation is a primary symptom of the disease, a side effect of neural inflammation would be like pouring gas on fire, principal investigator Dr. Chuanhai Caocompares.